Virtus Investment Advisers, LLC
Position in XERS — Xeris Biopharma Holdings, Inc.
CIK 19481
HARTFORD, CT
Position in XERS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,356,410
+$1,135,836 QoQ
Shares Held
171,264
+350.3% QoQ
Ownership
0.094%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#75
of 236 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Virtus Investment Advisers, LLC holds $9,997,407 across 9 Drug Manufacturers - Specialty & Generic names. XERS ranks #2 (13.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
22,411 | $1,433,183 | |
| 2 | XERS |
Xeris Biopharma Holdings, Inc.
This page
|
171,264 | $1,356,410 | |
| 3 | IRWD |
Ironwood Pharmaceuticals Inc
|
318,598 | $1,341,297 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
133,664 | $1,336,640 | |
| 5 | LQDA |
Liquidia Corp
|
16,326 | $1,301,671 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
7,279 | $1,226,802 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
2,130 | $1,154,097 | |
| 8 | BIOA |
BioAge Labs, Inc.
|
18,137 | $444,537 |
All Filings in XERS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,356,410 | 171,264 | Shares | Other | 2026-08-11 | |
| 2026-03-31 | $220,574 | 38,030 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $291,250 | 37,102 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $209,556 | 25,744 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $99,349 | 21,274 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $265,101 | 48,288 | Shares | Other | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||